Identification of mutated and non-mutated tumor-associated antigens in glioblastoma

Completed

• Conditions: glioblastoma; glioblastoma multiforme; 10029211

• Registration Number: NL-OMON38803
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 5

Inclusion Criteria

Age: >= 18 years
• Unresected primary or recurrent brain tumor
• Haemoglobin >= 10 g/100 ml
• Able to understand the research and give written informed consent

Exclusion Criteria

none

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Mutated and non-mutated tumor-associated antigens in glioblastoma</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>EU harmonized procedures for imuunmonitoring.<br /><br>A glioblastoma specific sHLA:peptidome.</p><br>